Literature DB >> 18303010

PI3K is a negative regulator of IgE production.

Tomomitsu Doi1, Kunie Obayashi, Takashi Kadowaki, Hideki Fujii, Shigeo Koyasu.   

Abstract

The production of IgE, a main player in allergic disorders such as asthma and atopic dermatitis, is strictly regulated and the serum concentrations of IgE are normally kept at a much lower level than other isotypes. We found that mice deficient for the p85alpha regulatory subunit of class IA phosphoinositide 3-kinase (PI3K) produced increasing amounts of serum IgE. Purified p85alpha-/- B cells produced more IgE than wild-type B cells in vitro in response to anti-CD40 mAb and IL-4. PI3K inhibitors wortmannin and IC87114 enhanced IgE production by wild-type B cells stimulated with anti-CD40 mAb and IL-4. Under the same condition, antigen receptor cross-linking induced the expression of inhibitor of differentiation-2 and suppressed the expression of activation-induced cytidine deaminase and class switch recombination (CSR) in a PI3K-dependent manner. IgE production was also suppressed in a concentrated cell culture condition, which was completely reversed by PI3K inhibition. The selective suppression of IgE production by PI3K was also observed at a protein level after CSR. Our results indicate that PI3K negatively regulates IgE production at both CSR and protein levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303010     DOI: 10.1093/intimm/dxn009

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

Review 1.  Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Authors:  G V Baracho; A V Miletic; S A Omori; M H Cato; R C Rickert
Journal:  Curr Opin Immunol       Date:  2011-02-01       Impact factor: 7.486

Review 2.  Phosphoinositide 3-Kinase in Asthma: Novel Roles and Therapeutic Approaches.

Authors:  Edwin J Yoo; Christie A Ojiaku; Krishna Sunder; Reynold A Panettieri
Journal:  Am J Respir Cell Mol Biol       Date:  2017-06       Impact factor: 6.914

Review 3.  PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances.

Authors:  Lomon So; David A Fruman
Journal:  Biochem J       Date:  2012-03-15       Impact factor: 3.857

4.  Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cells.

Authors:  Julia Bier; Geetha Rao; Kathryn Payne; Henry Brigden; Elise French; Simon J Pelham; Anthony Lau; Helen Lenthall; Emily S J Edwards; Joanne M Smart; Theresa S Cole; Sharon Choo; Avni Y Joshi; Roshini S Abraham; Michael O'Sullivan; Kaan Boztug; Isabelle Meyts; Paul E Gray; Lucinda J Berglund; Peter Hsu; Melanie Wong; Steven M Holland; Luigi D Notarangelo; Gulbu Uzel; Cindy S Ma; Robert Brink; Stuart G Tangye; Elissa K Deenick
Journal:  J Allergy Clin Immunol       Date:  2019-02-06       Impact factor: 10.793

Review 5.  PI3Ks in lymphocyte signaling and development.

Authors:  Klaus Okkenhaug; David A Fruman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

Review 6.  AID and somatic hypermutation.

Authors:  Robert W Maul; Patricia J Gearhart
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 7.  Regulation of IgE by T follicular helper cells.

Authors:  Uthaman Gowthaman; Jennifer S Chen; Stephanie C Eisenbarth
Journal:  J Leukoc Biol       Date:  2020-01-22       Impact factor: 4.962

8.  Imbalanced PTEN and PI3K Signaling Impairs Class Switch Recombination.

Authors:  Zhangguo Chen; Andrew Getahun; Xiaomi Chen; Yonatan Dollin; John C Cambier; Jing H Wang
Journal:  J Immunol       Date:  2015-10-23       Impact factor: 5.422

9.  Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation.

Authors:  Matthew Thomas; Matthew J Edwards; Elzbieta Sawicka; Nicholas Duggan; Emilio Hirsch; Matthias P Wymann; Charles Owen; Alexandre Trifilieff; Christoph Walker; John Westwick; Peter Finan
Journal:  Immunology       Date:  2008-08-27       Impact factor: 7.397

10.  KAP1 regulates gene networks controlling mouse B-lymphoid cell differentiation and function.

Authors:  Francesca R Santoni de Sio; Joanna Massacand; Isabelle Barde; Sandra Offner; Andrea Corsinotti; Adamandia Kapopoulou; Karolina Bojkowska; Antonis Dagklis; Marylise Fernandez; Paolo Ghia; James H Thomas; Daniel Pinschewer; Nicola Harris; Didier Trono
Journal:  Blood       Date:  2012-03-27       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.